Immunohistochemistry and gene knockdown studies showed OV expression of PKP3 and repression of apoptosis through silencing of death receptors (DRs) 4/5 by C-terminal-binding protein 2 in ovarian cancer cell lines, suggesting a role of these two proteins in the disease's progression [53, 54]. This evidence concerns the gene CTBP2 and ovarian carcinoma.